1-ethyl-2-benzimidazolinone has been researched along with Glioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsieh, YJ; Hsu, CW; Huang, CW; Huang, YM; Hung, TY; Sze, CI; Wu, SJ; Wu, SN; Yeh, PS | 1 |
Alzheimer, C; Burgstahler, R; Kaesler, S; Koegel, H; Werner, S | 1 |
2 other study(ies) available for 1-ethyl-2-benzimidazolinone and Glioma
Article | Year |
---|---|
Evidence for the Inhibition by Temozolomide, an Imidazotetrazine Family Alkylator, of Intermediate-Conductance Ca2+-Activated K+ Channels in Glioma Cells.
Topics: Alkylating Agents; Benzimidazoles; Cell Line, Tumor; Dacarbazine; DNA Damage; Glioma; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Ionomycin; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Temozolomide | 2016 |
Unexpected down-regulation of the hIK1 Ca2+-activated K+ channel by its opener 1-ethyl-2-benzimidazolinone in HaCaT keratinocytes. Inverse effects on cell growth and proliferation.
Topics: Benzimidazoles; Calcium Channel Agonists; Cell Division; Cell Line; Gene Expression Regulation; Glioma; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Ion Channel Gating; Keratinocytes; Kinetics; Membrane Potentials; Potassium Channels; Potassium Channels, Calcium-Activated; RNA, Messenger; Tumor Cells, Cultured | 2003 |